Pancreatic cancer remains one of the deadliest cancers known, but two independent experimental therapies have now ...
Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Imviva Biotech's CTD402 to accelerate the ...
A New Jersey woman has been given a second chance at life, thanks to a new cancer therapy. Pamela Goldberger, 65, found out in 2023 that she had glioblastoma — a devastating diagnosis with an average ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...
Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...
Researchers developed an innovative metal-organic framework that induces oxidative stress in tumors, leading to total cancer ...
Aviva Bio is advancing AVA-291 (d3-T) as a differentiated testosterone in a broad development program addressing multiple ...
The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after ...
A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published in Nature ...
Scientists at Mount Sinai have unveiled a bold new way to fight metastatic cancer by turning the tumor’s own defenses against ...
YD Bio Limited ('YD Bio Ltd” or the 'Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer ...